Retatrutide is setting new records at ~25% or more
More recently, they have been used for the treatment of obesity [16]
Maclusky NJ, Cook S, Scrocchi L, Shin J, Kim J, Vaccarino F, et al
"More frequent monitoring might be appropriate if you're losing weight rapidly, eating very little, experiencing significant fatigue, hair loss or treating a known deficiency," says Pratt
doi: 10.1016/j.neuropharm.2013.01.013 87 DowsettGKCLamBYHTadrossJACiminoIRimmingtonDCollAPet al
However, a national Blue Health Intelligence study from the Blue Cross Blue Shield Association finds that more than 30% of patients dropped out of treatment after the first four weeks and 58% of patients taking the medications for weight loss discontinued use before seeing a clinical benefit